Levetiracetam inhibits kindling-induced synaptic potentiation in the dentate gyrus of freely moving rats

Neuroscience Research

Volumn 66, Issue 2, 2010, Pages 228-231

  Sugaya, Yuki ^a   Jinde, Seiichiro ^a   Kato, Nobumasa ^c   Maru, Eiichi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiepileptic drug; Kindling; KIP; Levetiracetam; LTP; Perforant path; Rat

Indexed keywords

ETIRACETAM;

ARTICLE; DENTATE GYRUS; DRUG EFFICACY; EVOKED SOMATOSENSORY RESPONSE; EXCITATORY POSTSYNAPTIC POTENTIAL; KINDLING; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; DENTATE GYRUS; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; KINDLING, NEUROLOGIC; MALE; NEURAL INHIBITION; NEURONAL PLASTICITY; PERFORANT PATHWAY; PIRACETAM; RATS; RATS, WISTAR; SYNAPSES; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 74449093173     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2009.10.014     Document Type: Article

References (16)

1. Cain D.P., Boon F., and Hargreaves E.L. Evidence for different neurochemical contributions to long-term potentiation and to kindling and kindling-induced potentiation: role of NMDA and urethane-sensitive mechanisms. Exp. Neurol. 116 (1992) 330-338
2. 2+-induced exocytosis. J. Neurosci. 29 (2009) 883-897
3. Gilbert M.E., and Mack C.M. The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat. Brain Res. 519 (1990) 89-96
4. Goddard G.V., and Maru E. Forces for and against the kindled state as revealed by EEG and field potential analysis in the hippocampal dentate area of perforant path kindled rats. In: Wada J.A. (Ed). Kindling 3 (1986), Raven Press, New York 1-16
5. 2+ regulators in neurotransmitter release. Neuron 24 (1999) 1003-1016
6. Kaminski R.M., Gillard M., Leclercq K., Hanon E., Lorent G., Dassesse D., Matagne A., and Klitgaard H. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam. Epilepsia 50 (2009) 1729-1740
7. Kauer J.A., Malenka R.C., and Nicoll R.A. A persistent postsynaptic modification mediates long-term potentiation in the hippocampus. Neuron 1 (1988) 911-917
8. Lamberty Y., Margineanu D.G., and Klitgaard H. Absence of negative impact of levetiracetam on cognitive function and memory in normal and amygdala-kindled rats. Epilepsy Behav. 1 (2000) 333-342
9. Loscher W., Honack D., and Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J. Pharmacol. Exp. Ther. 284 (1998) 474-479
10. Lynch B.A., Lambeng N., Nocka K., Kensel-Hammes P., Bajjalieh S.M., Matagne A., and Fuks B. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc. Natl. Acad. Sci. USA 101 (2004) 9861-9866
11. Mazarati A.M., Baldwin R., Klitgaard H., Matagne A., and Wasterlain C.G. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus. Epilepsy Res. 58 (2004) 167-174
12. Michalakis M., Holsinger D., Ikeda-Douglas C., Cammisuli S., Ferbinteanu J., DeSouza C., DeSouza S., Fecteau J., Racine R.J., and Milgram N.W. Development of spontaneous seizures over extended electrical kindling. I. Electrographic, behavioral, and transfer kindling correlates. Brain Res. 793 (1998) 197-211
13. Mody I., and Heinemann U. NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling. Nature 326 (1987) 701-704
14. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 281-294
15. Sutula T., and Steward O. Facilitation of kindling by prior induction of long-term potentiation in the perforant path. Brain Res. 420 (1987) 109-117
16. Weiss S.R., Li X.L., Rosen J.B., Li H., Heynen T., and Post R.M. Quenching: inhibition of development and expression of amygdala kindled seizures with low frequency stimulation. Neuroreport 6 (1995) 2171-2176